Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Discovery Could Revolutionize Immunization

Published: Monday, April 29, 2013
Last Updated: Monday, April 29, 2013
Bookmark and Share
Immune cells in newborns appear to be more ready to do battle than previously thought.

New Cornell research shows that small populations of preprogrammed immune cells can fight specific pathogens that they have never encountered. The findings, say the researchers, have the potential to revolutionize how and when people are immunized.

The study, published in the March issue of the Journal of Immunology, demonstrates a way to grow these cells, potentially transforming our approach to preventing infectious disease.

When first exposed to a new pathogen, the immune system takes up to a week to effectively respond, and up to a month to make specialized memory cells that remember how to fight it. The next time a body is exposed, these memory cells take care of it within hours. Scientists had thought memory cells only developed after exposure, but Avery August, professor of microbiology and immunology, and his lab had discovered small pre-existing (innate) populations in 2008. Their defensive potential was unknown until the latest study found they act exactly like memory cells that learn from exposure.

“These fully functioning innate memory cells open amazing opportunities for improving how we immunize,” said August, chair of the Department of Microbiology and Immunology at Cornell’s College of Veterinary Medicine, who oversaw the study. “We’ve found a way to make millions of working memory cells without ever having to expose the body to a pathogen. If we can mobilize these cells to our advantage we can immunize much more quickly and eliminate the rare side effects of traditional vaccines.”

August

Vaccines work by stimulating immune cells to “remember” a pathogen. For example, by exposing the body to a particular strain, a vaccine helps the immune system learn to respond to it. Making memory cells directly could eliminate that learning curve, letting people bypass booster shots and some slower-acting vaccines, August said. People going abroad could get immunizations the day before they travel instead of weeks in advance.

Our bodies normally have about 100 memory cells at birth, according to August’s past research, but need about 100,000 to defend against the average invader. Using bone marrow chimeras, a specialized transplantation technique, the researchers were able to make 10 million. The study focused on memory cells designed to attack Listeria monocytogenes, bacteria that cause food poisoning, but August believes the model could be expanded to boost defenses against other infectious diseases.

“Theoretically we could generate memory cells for any kind of pathogen,” said August. “It looks like our immune systems are already trying to do this. The existence of these premade memory cells suggests that, over evolutionary history, our immune systems are trying to anticipate the pathogens we’ll face. Now we’ve found a way that could quickly help them along to improve immunities.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Wednesday, June 29, 2016
Synthetic Immune Organ Produces Antibodies
Cornell engineers have created a functional, synthetic immune organ that produces antibodies and can be controlled in the lab, completely separate from a living organism.
Friday, June 12, 2015
Expelled DNA that Traps Toxins May Backfire in Obese
The body’s most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight.
Wednesday, June 19, 2013
TB Bacteria's Trash-Eating Inspires Search for New Drugs
When hijacking a garbage truck, one might as well make use of the trash. That logic drives how tuberculosis-causing bacteria feed, say Cornell scientists.
Tuesday, June 11, 2013
Immune Response Linked to Key Enzyme
A family of enzymes may contribute to scientists’ understanding of signaling molecules involved in the body’s immune response.
Friday, April 12, 2013
Inflammation Drives Crohn's Disease, Says Study
Recent studies show marked changes in the composition of the intestinal bacteria in people with CD.
Tuesday, August 21, 2012
Bacteria Employ 'Quality-control' Machinery, say Biomolecular Engineers
Like quality-control managers in factories, bacteria possess built-in machinery that track the shape and quality of proteins trying to pass through their cytoplasmic membranes.
Friday, August 03, 2012
The Force is with us: GEDI Chip Sorts Prostate Cancer Cells
Geometrically Enhanced Differential Immunocapture chip identify and collect cancer cells from a patient's bloodstream.
Friday, June 29, 2012
Immune Cells Found to Counter Obesity-Related Diabetes
Activation of NKT cells reduces inflammation, and also reduces insulin resistance and increases glucose tolerance.
Monday, May 21, 2012
Scientific News
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
‘Antigen-presenting cell’ activates T cells by alerting them to the presence of tumors.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!